معرفی
Dr. Jun Wang serves as Research Associate Professor in the Department of Preventive Medicine at Northwestern University's Feinberg School of Medicine, specializing in the Division of Cancer Epidemiology and Prevention. His expertise bridges molecular biology and medical informatics to advance cancer prevention through biomarker discovery.
Dr. Wang's educational foundation includes:
- PhD from Peking Union Medical College (1997)
- MS from Northwestern University (2016)
- Postdoctoral Fellowship in Hematology/Oncology at Feinberg School of Medicine (2000)
His research program centers on Cancer Epidemiology with concentrated focus on Breast Cancer mechanisms, leveraging genomic and epigenetic approaches. He investigates DNA methylation, microRNA, and genetic polymorphisms as biomarkers for cancer risk assessment while examining steroid hormone-initiated signal transduction pathways. This translational work integrates medical informatics to develop prevention strategies targeting molecular pathways in carcinogenesis.
Analysis of his 2025 publications reveals a dominant emphasis on epigenetic mechanisms across diverse disease contexts. His team consistently applies DNA methylation profiling to address critical questions in cardiovascular disease prediction, cervical cancer in immunocompromised populations, biological aging metrics, and chemopreventive pharmacology - demonstrating cross-disciplinary application of epigenetic biomarkers for risk stratification and intervention development.
No scientific awards were documented in the provided materials.
Information regarding student mentorship and research grant funding was not disclosed in the source documentation.
Dr. Wang maintains active affiliations with Northwestern University Clinical and Translational Sciences Institute (NUCATS) and the Robert J. Havey, MD Institute for Global Health (IGH), facilitating his translational research in cancer epidemiology through institutional infrastructure and global health networks.
